Last reviewed · How we verify
AJ Vaccines A/S — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| IPV-Al | IPV-Al | marketed | Inactivated viral vaccine | Poliovirus serotypes 1, 2, and 3 | Immunology / Infectious Disease |
Therapeutic area mix
- Immunology / Infectious Disease · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Boryung Pharmaceutical Co., Ltd · 1 shared drug class
- Centers for Disease Control and Prevention · 1 shared drug class
- Chiang Mai University · 1 shared drug class
- China National Biotec Group Company Limited · 1 shared drug class
- Clover Biopharmaceuticals AUS Pty · 1 shared drug class
- Cogna Technology Solutions LLC · 1 shared drug class
- Crucell Holland BV · 1 shared drug class
- Bharat Biotech International Limited · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for AJ Vaccines A/S:
- AJ Vaccines A/S pipeline updates — RSS
- AJ Vaccines A/S pipeline updates — Atom
- AJ Vaccines A/S pipeline updates — JSON
Cite this brief
Drug Landscape (2026). AJ Vaccines A/S — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/aj-vaccines-a-s. Accessed 2026-05-17.